| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-14 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-12 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.31 | 5e-11 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-10 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-09 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-08 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |